Property:Appraisal clinical question

From Cancer Guidelines Wiki

This is a property of type Page. It links to pages that use the form Clinical question.

Pages using the property "Appraisal clinical question"

Showing 25 pages using this property.

(previous 25) (next 25)

1

1999 +What is the optimal systemic therapy for stage IV inoperable NSCLC?  +
1999 2 +What is the optimal systemic therapy regimen for patients with poor performance status for treatment of stage IV inoperable NSCLC?  +
1999 3 +What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?  +

2

2008 +Cancer chemotherapy medication safety guidelines  +
2009 +Cancer chemotherapy medication safety guidelines  +
2012 2 +Cancer chemotherapy medication safety guidelines  +
2013 2 +Cancer chemotherapy medication safety guidelines  +
2014 5 +Cancer chemotherapy medication safety guidelines  +

?

?ukaszewicz-Zajac M, Mroczko B, Koz?owski M, Nikli?ski J, Lauda?ski J, Szmitkowski M 2010 +Are there useful biomarkers to detect and improve the diagnosis of neoplasia in patients with or without BO?  +

A

AB Ogunrombi, UU Onakpoya, U Ekrikpo, AS Aderibigbe, OA Aladesuru 2014 +What is the optimal management of malignant pleural effusions?  +
ASHP Council on Professional Affairs 2002 +Cancer chemotherapy medication safety guidelines  +
Abacioglu U, Caglar H, Atasoy BM, Abdulloev T, Akgun Z, Kilic T 2010 +What is the role of stereotactic radiosurgery in the treatment of brain metastases?  +
Abatzoglou S, Turcotte RE, Adoubali A, Isler MH, Roberge D 2010 +What are the factors influencing the extent of surgery in BSTTs?  +
Abatzoglou S, Turcotte RE, Adoubali A, Isler MH, Roberge D 2010 2 +What is the evidence for radiotherapy in limb and extremity soft tissue sarcoma in terms of local recurrence, survival and limb salvage?  +
Abbas AE, Deschamps C, Cassivi SD, Allen MS, Nichols FC 3rd, Miller DL, et al 2004 +Are there any treatments that prevent progression of BO to cancer?  +
Abbott AM, Habermann EB, Parsons HM, Tuttle T, Al-Refaie W 2012 +What is the role of prognostic factors in management of BSTTs?  +
Abd-Alazeez M, Ahmed HU, Arya M, Charman SC, Anastasiadis E, Freeman A, et al 2014 +In men with suspected prostate cancer whose initial TRUS biopsy is negative, what should be the next investigation(s)?  +
Abd-Alazeez M, Ahmed HU, Arya M, Charman SC, Anastasiadis E, Freeman A, et al 2014 2 +In men with suspected prostate cancer whose initial TRUS biopsy is negative, what should be the next investigation(s)?  +
Abdel-Rahman O, ElHalawani H 2016 +What is the optimal first-line chemotherapy regimen in patients with stage IV inoperable NSCLC?  +
Abe S, Tokizaki T, Miki Y, Tateishi A, Ogawa K, Nakano H, et al 2005 +What is the role of regional chemotherapy in BSTTs?  +
Abela JE, Going JJ, Mackenzie JF, McKernan M, O'Mahoney S, Stuart RC 2008 2 +What is the optimal tissue sampling at endoscopy for diagnosis of BO?  +
Abellan JF, Lamo de Espinosa JM, Duart J, Patiño-García A, Martin-Algarra S, Martínez-Monge R, et al 2009 +Does referral to a specialist centre improve outcomes in BSTTs?  +
Abellan JF, Lamo de Espinosa JM, Duart J, Patiño-García A, Martin-Algarra S, Martínez-Monge R, et al 2009 2 +What is the impact of delay in referral to a specialist centre in BSTTs?  +
Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al 2011 +In people at risk of lung cancer, does population based screening with chest radiography reduce mortality?  +
Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al 2011 1 +In people at risk of lung cancer, does population based CT screening reduce mortality?  +
(previous 25) (next 25)